Welcome to the 21st EDA Annual Conference!
Oslo Delirium Research Group is delighted to invite you to the 21st European Delirium Association (EDA) Annual Conference, taking place in Oslo, Norway.
The EDA Annual Conference takes place on 5–6 November 2026. In addition, an optional pre-conference Pathophysiology Day will be held on 4 November 2026 for participants who wish to attend an extra day dedicated to the pathophysiology of delirium.
The conference venue is the Radisson Blu Scandinavia Hotel, perfectly located in the heart of Oslo.
The conference is organized by the Oslo Delirium Research Group. If you would like more information, please contact the Chair of the Organizing Committee, Bjørn Erik Neerland, at bjonee@ous-hf.no.
The Norwegian National Centre for Ageing and Health is happy to support Oslo Delirium Research Group by hosting this website.
Registration is now open, with early bird rates available until 31 July 2026
The final deadline for registration is 19 October 2026.
The Maeve Leonard Award, presented annually by the European Delirium Association, recognises an individual or group that has made an exceptional contribution to delirium awareness, knowledge, or care. The award will be presented at the conference in memory of Dr Maeve Leonard.
We look forward to welcoming you to Oslo in November 2026!
Key Dates
- Pathophysiology Symposium: 4 November 2026
- Main conference: 5–6 November 2026
Sponsors
Oslo Delirium Research Group gratefully acknowledges the support of our sponsors.
Infiniti Medical is a proud sponsor of the EDA Conference in Oslo, participating to represent Masimo and their commitment to advanced patient monitoring.
We aim to promote greater understanding of the importance of brain monitoring and oxygen delivery (DO₂), and how insights from these modalities can support more individualised treatment and better decision-making throughout the entire patient pathway.
We believe this is crucial for preventing postoperative complications, reducing the risk of delirium, and minimising complications during intensive care – with the ultimate goal of improving patient safety and clinical outcomes
QUMEA is the foresight engine for care. Founded in 2019, the Swiss company is headquartered in Solothurn, with subsidiaries in Mannheim, Germany, and Stockholm, Sweden.
QUMEA builds high-precision, radar-based monitoring systems that continuously capture movement data and translate it into actionable clinical intelligence, giving care teams the confidence to act in time.
With dignity at its core, the solution works entirely without cameras. More than 150 institutions across Europe already rely on QUMEA, backed by a team of over 60 experts.